SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Cipla
Cipla
BSE: 500087|NSE: CIPLA|ISIN: INE059A01026|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 10, 16:30
605.25
-18.2 (-2.92%)
VOLUME 209,387
LIVE
NSE
Dec 10, 16:30
605.50
-17.9 (-2.87%)
VOLUME 2,116,349
News on Cipla
Select Year: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Prefer Asian Paints for long term: Sudarshan Sukhani 

5.04 pm | 17 Dec 2014 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that one may prefer Asian Paints for long term....

Prefer banking, pharma stocks: Rahul Mohindar 

10.40 am | 13 Dec 2014 |  Source: CNBC-TV18

Rahul Mohindar of viratechindia.com is of the view that one may prefer banking and pharma stocks....

Cipla's arm Meditab sells stake in Jiangsu for USD 18.5 mn

3.16 pm | 10 Dec 2014 |  Source: PTI

The closing of the transaction is subject to receipt of applicable regulatory approvals in China, it added....

Cipla up 1.7%, subsidiary to sell stake in Chinese company

1.24 pm | 10 Dec 2014 |  Source: Moneycontrol.com

Meditab Holdings (Mauritius) a wholly owned subsidiary of the company, has entered into a definitive agreement to sell its entire 48.22 percent equity...

Cipla subsidiary to sell its entire stake in Jiangsu Cdymax Pharmaceuticals

11.01 am | 10 Dec 2014 |  Source: Moneycontrol.com

Cipla has informed that Meditab Holdings Limited, Mauritius, a wholly owned subsidiary of the Company, has entered into a definitive agreement to sell...

Strides Arcolab, Cipla to get astro support: Satish Gupta

10.43 am | 04 Dec 2014 |  Source: Moneycontrol.com

Pharma stocks such as Strides Arcolab, Wockhardt, Cipla, Glenmark and Biocon, FDC will be getting astrological support, says Satish Gupta of Astrostoc...

Nifty ends flat at 8537; midcaps outperform 

7.13 pm | 03 Dec 2014 |  Source: Moneycontrol.com

Nifty ended flat and the midcap outperformance is something that stood out in today’s trade. Amongst the Nifty gainers, Gujarat State Petronet Limit...

Meda and Cipla sue Apotex to enforce Dymista patents

1.24 pm | 03 Dec 2014 |  Source: Moneycontrol.com

Meda Pharmaceuticals Inc. and Cipla sued Apotex Inc. and Apotex Corp. in Federal District Court in Delaware to enforce the Orange-Book listed patents ...

Hold Cipla, says Sudarshan Sukhani 

12.21 pm | 03 Dec 2014 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com recommends holding Cipla with a long term view....

Cipla, Strides Arcolab ink collaboration pact with MMV

7.08 pm | 27 Nov 2014 |  Source: PTI

The collaborations are done under the MMV-led Improving Severe Malaria Outcomes project, funded by UNITAID, aims to develop a rectal artesunate produc...

Medicines for Malaria Venture announces collaborations with Cipla and Strides

2.40 pm | 27 Nov 2014 |  Source: Moneycontrol.com

Medicines for Malaria Venture signs collaboration agreements with two Indian pharmaceutical companies, Cipla and Strides Arcolab for the development o...

Six in Sixty: Stocks you should keep on your radar 

2.38 pm | 26 Nov 2014 |  Source: CNBC-TV18

CNBC-TV18's Sonia Shenoy lists out six stocks that you should focus....

Go long in Cipla, says Ashish Chaturmohta 

1.30 pm | 26 Nov 2014 |  Source: CNBC-TV18

Ashish Chaturmohta of Fortune Equity Broker recommends going long in Cipla as the stock may test Rs 680-690 in next five-seven trading sessions....

Colgate Palmolive looks expensive: Sanjeev Prasad 

11.11 am | 26 Nov 2014 |  Source: CNBC-TV18

According to Sanjeev Prasad, Senior Executive Director and Co-Head at Kotak Institutional Equities, Colgate Palmolive is looking expensive....

Market to correct if no reforms; like Dabur, Marico: Kotak 

10.08 am | 26 Nov 2014 |  Source: CNBC-TV18

Prasad is not too positive about earnings upgrades, and feels there could be fewer upgrades than what the market was expecting...

Mkt to see choppiness, stop loss at 8420: Sudarshan Sukhani 

9.31 am | 26 Nov 2014 |  Source: CNBC-TV18

Sudarshan Sukhani advises investors to trail stop losses and not targets, as he feels this market can give us any reward so there is no need to put a ...

Buy Cipla; target of Rs 694: Firstcall

10.32 am | 25 Nov 2014 |  Source: Moneycontrol.com

Brokerage house Firstcall Research is bullish on Cipla and has recommended buy rating on the stock with a target price of Rs 694 in its research repor...

Kotak Sec tweaks model portfolio; drops Colgate, adds Cipla

10.16 am | 25 Nov 2014 |  Source: Moneycontrol.com

The brokerage sees limited scope for re-rating given high valuations of stocks in the automobiles, banking, consumer and pharmaceutical sectors....

Market maintains bull run, experts remain bullish  

4.29 pm | 24 Nov 2014 |  Source: CNBC-TV18

Market expert Ambareesh Baliga believes market will move up over the next four-five days or one week. According to him, the appetite for such market i...

Buy Cipla for long term, says Parag Thakkar 

10.30 am | 24 Nov 2014 |  Source: CNBC-TV18

Parag Thakkar of HDFC Securities recommends going long in Cipla....

1 2 3 4 5 6
Quick Links for Cipla
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.